Passage BIO, Inc.|4Mar 29, 7:01 PM ET

Salinas Eliseo Oreste 4

4 · Passage BIO, Inc. · Filed Mar 29, 2021

Form 4

Period: 2021-03-22

Chief Res. & Develop Officer

Transactions

Award
Employee Stock Option (Right to buy)
2021-03-22+275,000→ 275,000 total
Exercise: $18.85Exp: 2031-03-22→ Common Stock (275,000 underlying)
Award
Restricted Stock Unit (RSU)
2021-03-22+60,000→ 60,000 total
→ Common Stock (60,000 underlying)
Award
Restricted Stock Unit (RSU)
2021-03-22+40,000→ 40,000 total
→ Common Stock (40,000 underlying)

Footnotes (4)

[F1]The option vests as to 25% of the total shares on March 22, 2022, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on March 22, 2025, subject to the reporting person's provision of service to the issuer on each vesting date.
[F2]Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
[F3]The RSUs shall vest as to 33.33% of the total shares each on June 15, 2021, September 15, 2021 and December 15, 2021, subject to the Reporting Person's continued service to the Issuer on each vesting date.
[F4]1/4 of the RSUs will vest on June 15, 2022, and the remainder will vest as to 1/4 of the total award in annual installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date.

Documents

1 file